- CNCE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Concert Pharmaceuticals (CNCE) S-3Shelf registration
Filed: 2 Mar 15, 12:00am
Exhibit 12
Computation of Ratio of Earnings to Fixed Charges (1)
The following table sets forth, for each of the periods presented, our ratio of earnings to fixed charges and our coverage deficiency. You should read this table in conjunction with the financial statements and notes incorporated by reference in this prospectus.
Years Ended December 31, | ||||||||||||||||
2014 | 2013 | 2012 | 2011 | |||||||||||||
Net loss | $ | (31,699 | ) | $ | (6,056 | ) | $ | (20,444 | ) | $ | (11,320 | ) | ||||
Ratio of earnings to fixed charges(1) | N/A | N/A | N/A | N/A | ||||||||||||
Coverage deficiency | $ | (31,699 | ) | $ | (6,056 | ) | $ | (20,444 | ) | $ | (11,320 | ) |
(1) | We did not record earnings for the years ended December 31, 2014, 2013, 2012 and 2011. Accordingly, our earnings were insufficient to cover fixed charges for such periods and we are unable to disclose a ratio of earnings to fixed charges for such periods. |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.